⌘K

Login Start Free

Home/Filings/4/0001209191-22-056889

4//SEC Filing

Vig Pamela 4

Accession 0001209191-22-056889

CIK 0001759425other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 9:43 PM ET

Size

5.5 KB

Accession

0001209191-22-056889

Insider Transaction Report

Form 4

Period: 2022-11-10

Mirum Pharmaceuticals, Inc.MIRM

Chief Scientific Officer

Transactions

Award
Common Stock
2022-11-10$17.05/sh+660$11,254→ 21,902 total

Holdings

Common Stock
(indirect: By Trust)
75,000

Footnotes (1)

[F1]This Form 4 is being filed voluntarily to report the acquisition of 660 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1

filerCIK 0001780069

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 9:43 PM ET
Size: 5.5 KB

View on SEC.gov